Free Trial

scPharmaceuticals (SCPH) SEC Filings & 10K Form

scPharmaceuticals logo
$3.39 +0.08 (+2.42%)
(As of 12/20/2024 05:16 PM ET)

Recent scPharmaceuticals SEC Filings

DateFilerForm TypeView
12/11/2024
5:30 AM
scPharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:48 PM
Lundbeckfond Invest A/S (Filed by)
scPharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
4:16 PM
scPharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/28/2024
3:30 PM
Nokes Rachael (Reporting)
scPharmaceuticals (Issuer)
Form 4/A
08/28/2024
3:30 PM
SCHAEFFER LEONARD D (Reporting)
scPharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:51 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
scPharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:47 PM
ORBIMED ADVISORS LLC (Filed by)
scPharmaceuticals (Subject)
Form SC 13D/A
08/13/2024
7:58 AM
scPharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:03 AM
scPharmaceuticals (Filer)
Form 424B5
08/12/2024
5:48 AM
scPharmaceuticals (Filer)
Form 424B5
08/12/2024
5:08 AM
scPharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:20 PM
scPharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
3:07 PM
scPharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
1:34 PM
LYTTON LAURENCE W (Filed by)
scPharmaceuticals (Subject)
Form SC 13G
04/26/2024
3:26 PM
scPharmaceuticals (Filer)
Form DEFA14A
04/26/2024
3:16 PM
scPharmaceuticals (Filer)
Form DEF 14A
04/12/2024
3:14 PM
scPharmaceuticals (Filer)
Form PRE 14A
04/05/2024
11:21 AM
BlackRock Inc. (Filed by)
scPharmaceuticals (Subject)
Form SC 13G/A
04/02/2024
3:15 PM
scPharmaceuticals (Issuer)
Tucker John H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2024
11:15 PM
scPharmaceuticals (Filer)
Form EFFECT
03/13/2024
3:49 PM
scPharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/13/2024
3:58 PM
scPharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/13/2024
3:08 PM
scPharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
3:25 PM
5AM Ventures IV, L.P. (Filed by)
scPharmaceuticals (Subject)
Form SC 13G/A
02/12/2024
5:06 AM
Rubric Capital Management LP (Filed by)
scPharmaceuticals (Subject)
Form SC 13G
02/07/2024
5:55 PM
HIRSCHMAN ORIN (Filed by)
scPharmaceuticals (Subject)
Form SC 13G/A
02/02/2024
11:35 AM
Cowen Financial Products LLC (Filed by)
scPharmaceuticals (Subject)
Form SC 13G/A
01/22/2024
7:27 PM
scPharmaceuticals (Issuer)
Tucker John H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
7:28 PM
Nokes Rachael (Reporting)
scPharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:30 PM
scPharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
3:31 PM
scPharmaceuticals (Issuer)
Tucker John H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SCPH) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners